Top Story

EYEGUARD-B study reaches target exacerbation event

May 29, 2015

The phase 3 EYEGUARD-B study of gevokizumab reached its target exacerbation event, according to a Xoma press release.

The EYEGUARD-B study is a randomized, double-masked, placebo-controlled study of the efficacy of gevokizumab in the treatment of patients with Behçet’s disease uveitis. The study is sponsored by Servier, the release said.

Business News

InSite quarterly revenue increases due to Nicox license agreement payment

May 29, 2015
InSite Vision reported $3.4 million in revenues in the first quarter 2015, an increase from $1.2 million in the first quarter of the previous year, according to a press…
VIDEO: Iris claw AC IOL may be preferred over angle-supported IOLs in pediatric cataract cases Meeting News CoverageVideo

VIDEO: Iris claw AC IOL may be preferred over angle-supported IOLs in pediatric cataract cases

May 29, 2015
KIAWAH ISLAND, S.C. — At the Kiawah Eye 2015 meeting here, Reid Turner, MD, discusses a study examining the safety of angle-supported anterior chamber IOLs and iris…
VIDEO: Scheimpflug lens densitometry an objective measure of lens opacity Meeting News CoverageVideo

VIDEO: Scheimpflug lens densitometry an objective measure of lens opacity

May 29, 2015
KIAWAH ISLAND, S.C. — At the Kiawah Eye 2015 meeting here, David Tremblay, MD, an ophthalmology resident at Storm Eye Institute, discusses a study attempting to use…
Breaking News

AAO airs concerns about beyond-use dates for repackaged Avastin

May 28, 2015
The American Academy of Ophthalmology has provided comments to the FDA expressing its concern that beyond-use dates for repackaged Avastin may limit the drug’s…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME
Challenges and Solutions in Retinal Vascular Disease: Pigment Epithelial Detachment and Refractory Diabetic Macular Edema

Challenges and Solutions in Retinal Vascular Disease: Pigment Epithelial Detachment and Refractory Diabetic Macular Edema

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

With anti-VEGF therapy well-established as front-line therapy in the management of age-related macular degeneration and…
More »
Meeting News Coverage Video
VIDEO: Scheimpflug lens densitometry an objective measure of lens opacity

VIDEO: Scheimpflug lens densitometry an objective measure of lens opacity

May 29, 2015
KIAWAH ISLAND, S.C. — At the Kiawah Eye 2015 meeting here, David Tremblay, MD, an ophthalmology resident at Storm Eye…
More »
morganatic-roan
morganatic-roan